Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity Terminated Phase 1 Trials for Gefitinib (DB00317)

IndicationStatusPhase
DBCOND0028768 (Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00033449Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck CancerTreatment